Discount Agreements for Rebif® (Interferon beta-1a)
AOK Bayern is seeking non-exclusive discount agreements for Rebif® (Interferon beta-1a) until July 31, 2028. The goal is to ensure supply of this important active ingredient.
CONTRACTING AUTHORITY
Name
AOK Bayern - Die Gesundheitskasse
City
München
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
715 days remaining(LOT-0001)
Published